Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Macaya Douoguih, Glenda Gray et al.|New England Journal of Medicine|2021Cited by 2.6k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, David C. Montefiori, Adrian B. McDermott et al.|Science|2022Cited by 1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Macaya Douoguih, Glenda Gray et al.|New England Journal of Medicine|2022Cited by 250
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Lindsey R. Baden, Holly Janes et al.|Annals of Internal Medicine|2022Cited by 138